10 patents currently held
10 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Oct 2027. from the record
Of the 10 now held by other companies, 5 name Bone Health Technologies Inc. as their current owner, and 5 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
4
Ending by 2030
Oct 2027
Next term end
7
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Apr 2028 · High confidence
Also notable
Ends Jun 2030 · High confidence
Also notable
Ends May 2033 · High confidence
Device and Method for Safe Access and Automated Therapy
US 11,800,992
Cited by 37 later US patents, top 5% of utility patents granted in 2023 in our data. Protection runs to 2028.
Continuous Blood Glucose Monitor
US 9,204,828
The most cited patent in this portfolio, cited by 68 later US patents, top 10% of utility patents granted in 2015 in our data. Protection runs to 2030.
Method of Monitoring Health Status of a Patient
US 11,241,179
Cited by 15 later US patents, top 10% of utility patents granted in 2022 in our data. Protection runs to 2033.
Formerly held, still cited
Notable
Ends Dec 2033 · High confidence
Cited by 15 later US patents, top 10% of utility patents granted in 2021 in our data. Protection runs to 2033.
now held by Bone Health Technologies, Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 13, 2026The maintenance fee for Methods and Devices for Treating and Managing Addiction (US 11,672,981) comes due Dec 13, 2026. Unpaid by Jun 14, 2027, it lapses early.
- 1 fee due Apr 30, 2027The maintenance fee for Device and Method for Safe Access and Automated Therapy (US 11,800,992) comes due Apr 30, 2027. Unpaid by Nov 1, 2027, it lapses early.
- 1 fee due Jun 8, 2027The maintenance fee for Continuous Blood Glucose Monitor (US 9,204,828) comes due Jun 8, 2027. Unpaid by Dec 8, 2027, it lapses early.
- 1 fee due Oct 23, 2027The maintenance fee for Method of Monitoring Health Status of a Patient (US 11,963,773) comes due Oct 23, 2027. Unpaid by Apr 24, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 16, 2026
- 1 term has ended since Aug 16, 2026
What they patent
The 5 largest of its 7 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Method of Monitoring Health Status of a Patient | 3 in force | to May 2033 |
| Continuous Blood Glucose Monitor | 2 in force | to Jun 2030 |
| Methods and Devices for Treating and Managing Addiction | 1 in force | to Apr 2039 |
| Multielectrode Ecg Sensor | 1 in force | to Oct 2036 |
| Devices and Methods for Determining Menstrual Blood Loss | 1 in force | to Sep 2034 |
Patents held now
Soonest term end first.
Showing 1 to 10 of 10
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,597,101 | Method and Apparatus for Personal Isolation And/Or Protection In force · High confidence | In force | High confidence | |
| US 11,800,992 | Device and Method for Safe Access and Automated Therapy In force · High confidence | In force | High confidence | |
| US 10,143,408 | Methods and Devices for the Diagnosis and Treatment of Diabetes In force · High confidence | In force | High confidence | |
| US 9,204,828 | Continuous Blood Glucose Monitor In force · High confidence | In force | High confidence | |
| US 12,507,929 | Method of Monitoring Health Status of a Patient In force · High confidence | In force | High confidence | |
| US 11,963,773 | Method of Monitoring Health Status of a Patient In force · High confidence | In force | High confidence | |
| US 11,241,179 | Method of Monitoring Health Status of a Patient In force · High confidence | In force | High confidence | |
| US 9,928,586 | Devices and Methods for Determining Menstrual Blood Loss In force · High confidence | In force | High confidence | |
| US 10,702,176 | Multielectrode Ecg Sensor In force · High confidence | In force | High confidence | |
| US 11,672,981 | Methods and Devices for Treating and Managing Addiction In force · High confidence | In force | High confidence |
Also on record, not counted in the 10: 10 patents in force now held by others · 14 patents ended · 4 applications pending · 20 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.